Search

everythinglearnresearchcommunity

for

Search:↓

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.

Mycophenolate mofetil may improve symptoms and stop hair loss in Lichen planopilaris, but more research is needed.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

Certain diets can affect skin conditions, but more research is needed to understand these relationships fully.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

The RORα gene is active in different parts of cashmere goat hair follicles and may be influenced by melatonin, especially in December when hair growth changes.

Stopping the antidepressant agomelatine improved hair loss in a patient.

Long-standing benign tumors can become cancerous, especially in people with weakened immune systems.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

Methotrexate injection site reactions are rare but can be managed by changing injection sites and using topical treatments.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

North American ginseng extract helped regrow hair in balding mice.

Early intervention and patient education are crucial for managing alopecia areata.

Cicatricial pattern hair loss is likely advanced common baldness, not a type of lichen planopilaris.

Blood count parameters are not reliable for predicting recurrent implantation failure.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Microorganism overgrowth and hyperkeratosis may trigger immune reactions causing lichen planopilaris.

Nivolumab can cause hair loss as a rare side effect.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Azathioprine can cause unexpected hair loss and severe bone marrow issues, so careful monitoring is needed.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.